Research Article on New York Times Research Section:
-large projective study-
Scientific research on 300,000 men and women ages 50 to 71, attempted to link self-reported use of aspirin and other nonsteroidal anti-inflammatory drugs with diagnoses of hepatocellular carcinoma and death from chronic liver disease.
The results were published online last week in The Journal of the National Cancer Institute and concluded that aspirin users had a 37% reduced risk of liver cancer and a 57% reduced rate of death from liver disease.
HOWEVER-I found it interesting, that the frequency of use(daily, weekly or monthly) didn't matter and those who took non-aspirin NSAIDs (ibuprofen, naproxen)had a 34 percent reduced risk of cancer, compared to those who did not.
- But they did not have a reduced risk of death from liver disease-
LINK TO ARTICLE: